PANACEA LIFE SCIENCES HOLDINGS, INC.
PLSHdata completeness 88%10 fiscal years on filePANACEA LIFE SCIENCES HOLDINGS, INC. earns about -47% on invested capital, and has bought back 62% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 |
|---|---|---|---|---|---|
| Revenue | $345,6801 | $9.02M2 | $2.06M3 | $1.63M4 | $2.38M4 |
| Net income | −$10M5 | −$5.23M6 | −$4.78M7 | −$9.14M8 | −$8.02M8 |
| Operating cash flow | −$5.75M9 | −$7.65M10 | −$3.92M11 | −$2.4M12 | −$1.52M12 |
| Capital expenditure | $541,20313 | $3.2M14 | $162,94615 | $243,80416 | $65,32216 |
| Free cash flow (derived) | −$6.29M9 | −$10.8M10 | −$4.09M11 | −$2.64M12 | −$1.59M12 |
| Total debt | $371,81217 | $1.03M17 | — | — | — |
| Cash & equivalents | $18,40518 | $84,37919 | $19,77420 | $6,95121 | $100,92221 |
| Diluted shares | 43.8M | 16.9M | 16.9M | 14.9M | 16.6M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$4.99 of net worth that earned you −$4.82 and generated −$0.96 of cash last year.
It earned an average -47% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 62% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has risen 178% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K/A · period ending 2019-12-31 · accession 0001654954-21-004566 (Revenues)
- 10-K · period ending 2020-12-31 · accession 0001493152-22-008215 (Revenues)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-009742 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-012107 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K/A · period ending 2019-12-31 · accession 0001654954-21-004566 (NetIncomeLoss)
- 10-K · period ending 2020-12-31 · accession 0001493152-22-008215 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-009742 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-012107 (NetIncomeLoss)
- 10-K/A · period ending 2019-12-31 · accession 0001654954-21-004566 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2020-12-31 · accession 0001493152-22-008215 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-009742 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-012107 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A · period ending 2019-12-31 · accession 0001654954-21-004566 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2020-12-31 · accession 0001493152-22-008215 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-009742 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-012107 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K/A · period ending 2019-12-31 · accession 0001654954-21-004566 (LongTermDebtCurrent)
- 10-K/A · period ending 2019-12-31 · accession 0001654954-21-004566 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2020-12-31 · accession 0001493152-22-008215 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-009742 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-012107 (CashAndCashEquivalentsAtCarryingValue)